🟢 Kura Oncology is trading 5.3% up

Kura Oncology is trading at $10.42, up 5.25%, with no confirmed new announcement explaining the October 28 move.

• A report on KO-7246 diabetes plans covered a strategy already announced October 13.
• The supplied sector context reports XBI up 2.18% during the regular session, but this does not establish the cause of Kura Oncology’s gain.
• Supplied market indices are mixed, and no trading-volume information is available.